Paragon 28 EBITDA Margin 2020-2022 | FNA

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Paragon 28 (FNA) over the last 10 years. The current EBITDA margin for Paragon 28 as of June 30, 2022 is .
Paragon 28 EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2022-06-30 $0.16B $-0.01B -8.64%
2022-03-31 $0.16B $-0.01B -5.13%
2021-12-31 $0.15B $-0.00B -1.35%
2021-06-30 $0.10B $0.01B 6.06%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.486B $0.147B
Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $227.578B 23.18
Edwards Lifesciences (EW) United States $62.887B 44.49
Alcon (ALC) Switzerland $36.987B 31.32
STERIS (STE) Ireland $20.913B 25.96
Teleflex (TFX) United States $11.693B 18.63
Fresenius Medical Care AG KGaA (FMS) Germany $10.936B 10.09
Globus Medical (GMED) United States $6.491B 32.38
Penumbra (PEN) United States $6.042B 724.86
Glaukos (GKOS) United States $2.370B 0.00
Integer Holdings (ITGR) United States $2.345B 18.34
Nevro (NVRO) United States $1.688B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.365B 20.90
Artivion (AORT) United States $0.860B 82.00